Using Acetazolamide to Treat Obstructive Sleep Apnea
Official title: Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea
Run by University of California, San Diego · NCT05804084 · Data updated 2026-11-12
This study is testing if a medication called acetazolamide can help adults with moderate to severe obstructive sleep apnea breathe better at night and feel more rested during the day.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | May 16, 2023 |
| Main results expected | October 31, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT05804084 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with untreated moderate to severe obstructive sleep apnea and a body mass index of 35 kg/m2 or less.
✕Probably not a fit
Patients with significant sleep hypoxemia, other major sleep disorders, or those requiring immediate OSA therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of acetazolamide, a mild diuretic, in treating adults with moderate to severe obstructive sleep apnea (OSA). Participants will be randomly assigned to receive either acetazolamide or a placebo for four weeks, during which their sleep patterns and neurocognitive functions will be monitored. The study will include eligibility screenings, in-person assessments, and an overnight sleep test to ensure participants meet the criteria. The primary goals are to determine if acetazolamide improves OSA symptoms and enhances quality of life compared to placebo.
Why it matters
Potential benefit: If successful, this treatment could provide a new, effective, and well-tolerated option for patients suffering from obstructive sleep apnea.
How similar studies have gone: While acetazolamide has been used for various conditions, this specific application for obstructive sleep apnea is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Body mass index ≤ 35 kg/m2 * Untreated moderate/severe OSA (AHI ≥15/h) Exclusion Criteria: * Substantial sleep hypoxemia (SpO2\<80% for \>10% of the monitoring time during the home sleep test, or for \>25% of the total sleep time during any of the in-laboratory studies) * Abnormally low blood counts/electrolytes or renal function at baseline * Use of OSA therapy during the past 1 month, or plans to urgently resume/(re)start clinical OSA therapy within 3 months * Significant, uncontrolled cardiac, pulmonary, endocrine, renal, hepatic, neurocognitive, psychiatric, or urologic (e.g., kidney stones) disorder * Other major sleep disorder (e.g., narcolepsy) * Urgent need to initiate effective OSA therapy (i.e., Epworth sleepiness score \>18, commercial driver, prior sleep-related car accident, or based on MD judgment) * Severe allergy to sulfa-drugs or taking another carbonic-anhydrase inhibitor (e.g., topiramate) * Pregnancy/breastfeeding (current/planned) * Prisoners * Illicit substance abuse or \>2 standard drinks of alcohol/day * Medications that may affect OSA or ventilatory control (e.g., opiates, sedatives) * Thiazide/loop diuretic (risk of hypokalemia) * Inability to give consent or follow procedures * Safety concern based on MD judgment
Where it's running
-
UC San Diego; Altman Clinical and Translational Research Institute Building
La Jolla, California, United States Recruiting
Study contacts
- Principal investigator: Christopher N Schmickl, MD, PhD — University of California, San Diego
- Study coordinator: Pamela DeYoung, RPSGT
- Email: sleepresearch@health.ucsd.edu
- Phone: 858 246 2183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.